Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(Q2)Sep 30, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
---|---|---|---|
Assets | |||
Current assets | |||
Cash, cash equivalents and short term investments | --2.55B | -0.64%4.44B | --4.47B |
-Cash and cash equivalents | --2.55B | -0.64%4.44B | --4.47B |
Receivables | --658.34M | 15.70%663.4M | --573.4M |
-Accounts receivable | --658.34M | 15.70%663.4M | --573.4M |
-Gross accounts receivable | --658.34M | 15.70%663.4M | --573.4M |
Inventory | --1.68M | -52.84%1.62M | --3.44M |
Prepaid assets | --95.39M | -3.46%71.36M | --73.92M |
Other current assets | --5.54M | -54.76%2.13M | --4.7M |
Total current assets | --3.31B | 1.06%5.18B | --5.12B |
Non current assets | |||
Net PPE | --104.52M | 3.11%101.16M | --98.11M |
-Gross PP&E | --196.51M | 24.58%178.9M | --143.61M |
-Accumulated depreciation | ---91.99M | -70.88%-77.75M | ---45.5M |
Prepaid assets-non current | --240.56M | -3.33%244.77M | --253.21M |
Total investment | --4.09M | -9.45%6.74M | --7.45M |
-Financial asset investment | --4.09M | -9.45%6.74M | --7.45M |
-Including:Available-for-sale securities | --4.09M | -9.45%6.74M | --7.45M |
Goodwill and other intangible assets | --4.59M | 16.55%5.55M | --4.76M |
-Other intangible assets | --4.59M | 16.55%5.55M | --4.76M |
Deferred tax assets-non current | --143.75M | 29.20%143.76M | --111.27M |
Other non current assets | --12.1M | 18.13%17.77M | --15.04M |
Total non current assets | --509.61M | 6.11%519.74M | --489.83M |
Total assets | --3.82B | 1.50%5.7B | --5.61B |
Liabilities | |||
Current liabilities | |||
Financial liabilities | --7.7M | 1.76%7.63M | --7.5M |
-Current debt and capital lease obligation | --7.7M | 1.76%7.63M | --7.5M |
-Including:Current capital Lease obligation | --7.7M | 1.76%7.63M | --7.5M |
Payables | --441.92M | 44.75%410.27M | --283.43M |
-Total tax payable | --296.62M | 40.36%262.36M | --186.92M |
-Other payable | --145.3M | 53.26%147.91M | --96.51M |
Accrued and deferred income | --20.04M | 25.18%12.36M | --9.87M |
Other current liabilities | --973.42M | -11.58%2.88B | --3.26B |
Current liabilities | --1.44B | -6.97%3.31B | --3.56B |
Non current liabilities | |||
Non current financial liabilities | --9.6M | -36.17%13.46M | --21.09M |
-Long term debt and capital lease obligation | --9.6M | -36.17%13.46M | --21.09M |
-Including:Long term capital lease obligation | --9.6M | -36.17%13.46M | --21.09M |
Other non current liabilities | --1K | -50.00%2K | --4K |
Total non current liabilities | --9.6M | -36.17%13.47M | --21.1M |
Total liabilities | --1.45B | -7.14%3.32B | --3.58B |
Shareholders'equity | |||
Share capital | --100M | 0.00%100M | --100M |
-common stock | --100M | 0.00%100M | --100M |
Additional paid-in capital | --1.21B | 0.00%1.21B | --1.21B |
Retained earnings | --1.02B | 48.27%1.03B | --693.95M |
Other reserves | --3.78M | 42.08%4.2M | --2.96M |
Total stockholders'equity | --2.33B | 16.75%2.34B | --2.01B |
Noncontrolling interests | --35.98M | 13.59%29.16M | --25.68M |
Total equity | --2.37B | 16.71%2.37B | --2.03B |
Currency Unit | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |